 Adovastatin, a commonly prescribed statin drug, has been shown to reduce the risk of cardiovascular disease in patients with coronary artery disease. In this study, researchers examined the effects of adovastatin on homocysteine levels in renal transplant recipients. The results showed that adovastatin significantly reduced homocysteine levels in these patients, suggesting that it may be beneficial for reducing the risk of cardiovascular disease in this population. This article was authored by Ali Monfaird, Syed Zainab Azimi and Eson Kazem Nezid.